Clinical trial · Interventional
Addressing Disparities in Cancer Care for Latino Medicare Beneficiaries
NCT00385866CI-TRIAL-00021840completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To reduce Cancer health care disparities that exists among minority Medicare beneficiaries and to demonstrate cost effectiveness of patient navigation in reducing the burden of cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cancer screening and health education | Behavioral | — | UNRESOLVED |
| facilitation of Services to improve cancer screening | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Comparison Group
- description
- The control or lesser intervention group, will receive cancer screening information on a quarterly basis, with no facilitation of services.
- interventionNames
- Behavioral: cancer screening and health education
- type
- ACTIVE_COMPARATOR
- label
- Intervention group
- description
- The intervention group are those participants who were randomly assigned to receive facilitation of services in the form of patient navigation for the duration of the study.
- interventionNames
- Behavioral: cancer screening and health education
- Behavioral: facilitation of Services to improve cancer screening
Primary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: Cancer-Negative Group 1. Be of Hispanic/Latino Origin 2. Fluent in English and/or Spanish 3. Recipient of, Medicare Part A \& B, or combined Medicare/Medicaid 4. Not having a previous diagnosis of cancer 5. Be capable of giving written informed consent prior to any study related procedures. 6. Be available and willing to complete all study assessments as specified. Cancer-Positive Group 1. Be of Hispanic/Latino Origin 2. Fluent in English and/or Spanish 3. Recipient of, Medicare Part A \& B, or combined Medicare/Medicaid 4. Having a previous diagnosis of cancer of the breast, cervix, colon and/or rectum, prostate, or lung. 5. Be capable of giving written informed consent prior to any study related procedures. 6. Be available and willing to complete all study assessments as specified. Exclusion Criteria: 1. Member of the Medicare Advantage Plan, any Medicare managed care plan (Those who join the Medicare Advantage plan or a managed care plan during the course of the study will become ineligible to continue.) 2. Medicaid only beneficiaries 3. Institutionalized 4. Unable to provide written informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.